back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-05-24 18:52 Tx date 2024-05-23 |
$ABUS
Arbutus Biopharma Corporation |
Meyers, James Robert
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$219,760
+67,000 vol $3.28 each |
273,000 | |
| Filed 2023-05-26 17:23 Tx date 2023-05-24 |
$ABUS
Arbutus Biopharma Corporation |
Meyers, James Robert
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$140,800
+55,000 vol $2.56 each |
206,000 | |
| Filed 2022-05-26 22:05 Tx date 2022-05-25 |
$ABUS
Arbutus Biopharma Corporation |
Meyers, James Robert
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$92,250
+41,000 vol $2.25 each |
151,000 | |
| Filed 2021-06-07 20:26 Tx date 2021-06-03 |
$ABUS
Arbutus Biopharma Corporation |
Meyers, James Robert
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$64,900
+22,000 vol $2.95 each |
110,000 | |
| Filed 2020-06-01 17:41 Tx date 2020-05-28 |
$ABUS
Arbutus Biopharma Corporation |
Meyers, James Robert
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$47,520
+22,000 vol $2.16 each |
88,000 | |
| Filed 2019-08-20 16:31 Tx date 2019-08-17 |
$ABUS
Arbutus Biopharma Corporation |
Meyers, James Robert
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$33,000
+22,000 vol $1.50 each |
66,000 | |
| Filed 2018-11-14 Tx date 2018-10-18 |
$ABUS
Arbutus Biopharma Corporation |
Meyers, James Robert
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-11-14 Tx date 2018-10-18 |
$ABUS
Arbutus Biopharma Corporation |
Meyers, James Robert
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-11-14 Tx date 2018-10-18 |
$ABUS
Arbutus Biopharma Corporation |
Meyers, James Robert
4 - Director of Issuer
Direct Ownership
|
Convertible Preferred Shares Series A
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-11-14 Tx date 2018-10-18 |
$ABUS
Arbutus Biopharma Corporation |
Meyers, James Robert
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$207,240
+44,000 vol $4.71 each |
44,000 |